Legal & General Group’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $302K | Sell |
13,992
-1,630
| -10% | -$30.1K | ﹤0.01% | 2469 |
|
|
2025
Q4 | $214K | Sell |
15,622
-73
| -0.5% | -$1.14K | ﹤0.01% | 2577 |
|
|
2025
Q3 | $278K | Sell |
15,695
-6,720
| -30% | -$106K | ﹤0.01% | 2563 |
|
|
2025
Q2 | $338K | Buy |
22,415
+8,197
| +58% | +$136K | ﹤0.01% | 2539 |
|
|
2025
Q1 | $229K | Sell |
14,218
-4,085
| -22% | -$76.1K | ﹤0.01% | 2590 |
|
|
2024
Q4 | $319K | Buy |
18,303
+3,521
| +24% | +$62.1K | ﹤0.01% | 2595 |
|
|
2024
Q3 | $259K | Buy |
14,782
+12,542
| +560% | +$214K | ﹤0.01% | 2635 |
|
|
2024
Q2 | $25.1K | Buy |
2,240
+792
| +55% | +$7.46K | ﹤0.01% | 2939 |
|
|
2024
Q1 | $12.6K | Hold |
1,448
| – | – | ﹤0.01% | 3151 |
|
|
2023
Q4 | $17.7K | Sell |
1,448
-107
| -7% | -$741 | ﹤0.01% | 3075 |
|
|
2023
Q3 | $6.27K | Hold |
1,555
| – | – | ﹤0.01% | 3344 |
|
|
2023
Q2 | $11.2K | Buy |
+1,555
| New | +$9.93K | ﹤0.01% | 3299 |
|
|
2022
Q2 | – | Sell |
-1,535
| Closed | -$7K | – | 3623 |
|
|
2022
Q1 | $7K | Buy |
1,535
+83
| +6% | +$679 | ﹤0.01% | 3470 |
|
|
2021
Q4 | $22K | Hold |
1,452
| – | – | ﹤0.01% | 3248 |
|
|
2021
Q3 | $31K | Sell |
1,452
-66
| -4% | -$1.42K | ﹤0.01% | 3117 |
|
|
2021
Q2 | $25K | Hold |
1,518
| – | – | ﹤0.01% | 3215 |
|
|
2021
Q1 | $36K | Sell |
1,518
-165
| -10% | -$4.93K | ﹤0.01% | 2929 |
|
|
2020
Q4 | $40K | Hold |
1,683
| – | – | ﹤0.01% | 2865 |
|
|
2020
Q3 | $20K | Sell |
1,683
-433
| -20% | -$4.66K | ﹤0.01% | 2970 |
|
|
2020
Q2 | $22K | Buy |
2,116
+359
| +20% | +$3.23K | ﹤0.01% | 3030 |
|
|
2020
Q1 | $13K | Sell |
1,757
-426
| -20% | -$4.42K | ﹤0.01% | 3090 |
|
|
2019
Q4 | $29K | Buy |
2,183
+394
| +22% | +$5.61K | ﹤0.01% | 3065 |
|
|
2019
Q3 | $28K | Hold |
1,789
| – | – | ﹤0.01% | 3000 |
|
|
2019
Q2 | $24K | Hold |
1,789
| – | – | ﹤0.01% | 3129 |
|
|
2019
Q1 | $31K | Hold |
1,789
| – | – | ﹤0.01% | 2914 |
|
|
2018
Q4 | $21K | Hold |
1,789
| – | – | ﹤0.01% | 3059 |
|
|
2018
Q3 | $25K | Hold |
1,789
| – | – | ﹤0.01% | 3120 |
|
|
2018
Q2 | $27K | Buy |
1,789
+48
| +3% | +$813 | ﹤0.01% | 3071 |
|
|
2018
Q1 | $24K | Sell |
1,741
-578
| -25% | -$11K | ﹤0.01% | 3064 |
|
|
2017
Q4 | $55K | Sell |
2,319
-97
| -4% | -$2.29K | ﹤0.01% | 2834 |
|
|
2017
Q3 | $46K | Hold |
2,416
| – | – | ﹤0.01% | 2931 |
|
|
2017
Q2 | $83K | Buy |
+2,416
| New | +$66.4K | ﹤0.01% | 2702 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
Legal & General Group's PLSE Position: Q1 2026 in Review
Legal & General Group reduced its Pulse Biosciences (PLSE) stake by 10% in Q1 2026, selling an estimated $30.1K and leaving 13,992 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.
Legal & General Group first reported a position in PLSE in Q2 2017 and has held it in 32 quarters since. The position peaked at $338K in Q2 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Legal & General Group held 13,992 shares of Pulse Biosciences worth $302K as of Q1 2026.
- Legal & General Group sold 1,630 Pulse Biosciences shares in Q1 2026, an estimated $30.1K.
- Pulse Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2469 holding.
- Legal & General Group first reported a position in Pulse Biosciences in Q2 2017 and has held it in 32 quarters since.
- Legal & General Group's Pulse Biosciences position peaked at $338K in Q2 2025.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.